Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Emma Jesson brings you Saturday night's forecast
Think-tank IPPR North has suggested a so-called Northern Brexit Negotiating Committee to advise the Government on Brexit
As October starts are we seeing more autumnal weather?